GlucoTrack to Issue Warrants for 406,198 Shares in Private Placement

• GlucoTrack agreed on October 13, 2026, to issue unregistered warrants to purchase 406,198 common shares in exchange for holder waivers.
• The new warrants carry a $7.5 exercise price and expire five years from issuance.
• Exercise requires stockholder approval of the underlying share issuance and is subject to a 9.99% beneficial ownership limit.
• The waivers remove share issuance restrictions; variable-rate transaction exercise-price adjustments are waived only for existing warrants held by signatories.
• Exercise-price adjustments for the new warrants have a floor of 20% of the common stock’s closing sale price on issuance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-047582), on October 19, 2026, and is solely responsible for the information contained therein.